Quarterly Profit
Sun Pharmaceuticals quarterly profit rose on the back of lower operating expenses and higher other income.Net profit rose 70% year-on-year to Rs 1,813 crore in the three months ended September, India’s largest drugmaker said in an exchange filing.
That compares with the Rs 1,124-crore consensus estimate of analysts tracked by Bloomberg. The company had reported a net loss of Rs 1,656 crore in the preceding quarter.
Sun Pharma Stock - past 1 year
Sun Pharma Stock - past 5 years
About Sun Pharma
According to Wikipedia - Sun Pharmaceuticals was established by Mr. Dilip Shanghvi in 1983 in Vapi, Gujarat, with five products to treat psychiatry ailments.Cardiology products were introduced in 1987 followed by gastroenterology products in 1989.
Today, it is the largest chronic prescription company in India and a market leader in psychiatry, neurology, cardiology, orthopedics, ophthalmology, gastroenterology and nephrology.
The 2014 acquisition of Ranbaxy made Sun the largest pharma company in India, the largest Indian pharma company in the US, and the 5th largest speciality generic company globally.
(Disclaimer : This blog is for information purposes and not to solicit business or provide any investment advise)
